Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ AI Dermatology — Free Service Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Confluent and reticulated papillomatosis (CRP), ebizwa nangokuthi i‑Gougerot‑Carteaud syndrome, ibonisa ukukhula okungavamile kwamangqamuzana esikhumba. Ibonakala njengamachashaza amnyama angenabuhlungu, ahlangana abe neziqephu ezinkulu, ngokuvamile avele phezulu esifubeni nasentanyeni, ikakhulukazi ebantwaneni naseminyakeni yobudala. Ukukhetha kokuqala kokwelashwa kunguminycicline (minocycline). Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
I-CRP ivamise ukuvela njengamachashaza amnyama nama‑patches ngaphandle kwezimpawu esikhumbeni esizungeze intamo, amakhwapha, isifuba esingenhla, kanye nendawo engaphezulu. Kwesinye isikhathi, ingasakazeka iye esiphongweni futhi yehle endaweni ye‑pubic. Imithi elwa namagciwane efana ne‑minocycline iyinketho yokwelashwa ekhethwayo. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ Ukwelashwa
#Minocycline